{
  "meta": {
    "title": "32_Disorders_Of_The_Pituitary_Gland",
    "url": "https://brainandscalpel.vercel.app/32-disorders-of-the-pituitary-gland-14fc2a13.html",
    "scrapedAt": "2025-11-30T12:33:12.717Z"
  },
  "questions": [
    {
      "text": "Which of the following is the most common tumor associated with growth hormone deficiency in children?",
      "choices": [
        {
          "id": 1,
          "text": "Prolactinoma"
        },
        {
          "id": 2,
          "text": "Craniopharyngioma"
        },
        {
          "id": 3,
          "text": "Pinealoma"
        },
        {
          "id": 4,
          "text": "Somatotropinoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>most common tumor</strong> associated with growth hormone (GH) deficiency in children is <strong>craniopharyngioma</strong>.</p>\n<p>Growth hormone deficiency can be caused by congenital<strong> CNS malformations, genetic</strong> defects or acquired <strong>neurological insults.</strong></p>\n<p>Note:</p>\n<ul>\n<li>Most common cause of GH deficiency: <strong>Idiopathic</strong></li>\n<li>Most common <strong>infection</strong> causing GH deficiency in India: <strong>Tuberculosis</strong> &gt; Histoplasmosis</li>\n<li>Most common <strong>infiltration</strong> causing GH deficiency in India: <strong>Histiocytosis</strong> &gt; Sarcoidosis.</li>\n<li><strong>Trophic hormone failure</strong> with pituitary compression or destruction: <strong>GH&gt; FSH&gt; LH&gt; TSH&gt; ACTH.</strong></li>\n<li>Most common tumors associated with central diabetes insipidus: Pinealomas, Germinomas&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1981",
      "difficulty": "medium"
    },
    {
      "text": "Asha was being bullied about her height in school. The concerned parents bring her to the pediatrician who plots the growth chart as shown below. On evaluation, growth hormone levels are found to be high and insulin-like growth factor levels are low. Which among the following could be a cause?",
      "choices": [
        {
          "id": 1,
          "text": "Turner's Syndrome"
        },
        {
          "id": 2,
          "text": "Pituitary Dwarfism"
        },
        {
          "id": 3,
          "text": "Laron Syndrome"
        },
        {
          "id": 4,
          "text": "Maternal Deprivation Dwarfism"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The presence of high GH&nbsp;levels and low insulin-like growth factor&nbsp;<strong>(IGF-1) </strong>levels point towards&nbsp;<strong>Laron syndrome/dwarfism.</strong>&nbsp;It&nbsp;is caused by&nbsp;<strong>end-organ resistance </strong>to growth hormone(GH insensitivity)&nbsp;due to the <strong>GH receptor mutation.&nbsp;</strong>It is an&nbsp;<strong>autosomal-recessive</strong>&nbsp;disorder with clinical features as those seen in&nbsp;pituitary dwarfism.</p>\n<p>Here, growth hormone is produced but is unable to act on the target tissues. Thus, the resting and stimulated GH&nbsp;levels&nbsp;are&nbsp;high&nbsp;and&nbsp;IGF-1&nbsp;levels are&nbsp;low.</p>\n<p>In <strong>Turner's syndrome </strong>(Option A), loss of the short arm of the X chromosome is implicated in dwarfism. The short stature occurs due to a state of GH resistance, relative deficiency, and decreased utilization.</p>\n<p><strong>Pituitary dwarfism</strong> (Option B)&nbsp;is a condition with GH deficiency.</p>\n<p><strong>Maternal deprivation dwarfism</strong>&nbsp;(Option D) is due to psychosocial causes such as emotional deprivation and neglect. There is an inadequate response to GH stimulation tests. The mechanism is not fully understood. No history suggestive of disturbed maternal or family relationships rules this out.&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a11ace36184840b69c78db5fadb0e9f1.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2403",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most common genetic cause for multiple pituitary hormone deficiency?",
      "choices": [
        {
          "id": 1,
          "text": "Mutations of GNAS1 gene"
        },
        {
          "id": 2,
          "text": "Mutations of c-MYC gene"
        },
        {
          "id": 3,
          "text": "Mutations of WT-1 gene"
        },
        {
          "id": 4,
          "text": "Mutations of PROP1 gene"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>most common genetic cause</strong> for multiple pituitary hormone deficiencies <strong>(MPHD)/panhypopituitarism</strong> is the&nbsp;mutation of the&nbsp;<em> <strong>PROP1</strong></em> gene.</p>\n<p><em>LHX3</em> and&nbsp;<em>GLI2</em> are other genes involved in MPHD.</p>\n<p><em>GNAS1</em> mutations cause McCune Albright Syndrome.&nbsp;</p>\n<p><em>c-MYC</em> gene is mutated in Burkitt's lymphoma&nbsp;</p>\n<p><em>WT-1</em> gene is mutated in Wilms tumors.&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1979",
      "difficulty": "medium"
    },
    {
      "text": "You come across a child with growth hormone deficiency during your ward rounds. Which of the following features would you not expect in this child?",
      "choices": [
        {
          "id": 1,
          "text": "History of short stature at birth"
        },
        {
          "id": 2,
          "text": "High-pitched voice"
        },
        {
          "id": 3,
          "text": "Normal intelligence"
        },
        {
          "id": 4,
          "text": "Proportionate short stature"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Children with growth hormone deficiency usually have&nbsp;<strong>normal growth at birth. G</strong><strong>rowth retardation</strong>&nbsp;(decline in growth velocity) becomes apparent around <strong>1 year</strong> of age.&nbsp;</p>\n<p>Growth <strong>in-utero</strong> is dependant on <strong>genetic, environmental, nutrition</strong> and <strong>growth factors.</strong> GH levels peak at mid-gestation, increase at birth, and then reduce by 2 weeks of life. At around <strong>6 months</strong> of age, <strong>GH</strong> levels reach <strong>pre-pubertal levels</strong> and from there on have a major <strong>influence</strong> on <strong>growth.</strong>&nbsp;Thus the deficiency becomes apparent after a significant period of GH-dependent growth has occurred.&nbsp;</p>\n<p><strong>Characteristic</strong> features of <strong>growth hormone deficiency</strong> (<strong>Pituitary Dwarfism</strong>):</p>\n<ol>\n<li>Normal growth at birth&nbsp;with growth retardation becoming apparent around 1 year of age</li>\n<li><strong>Proportionate short stature</strong></li>\n<li>Hypoglycemic seizures in newborn</li>\n<li>Small larynx with a&nbsp;<strong>high-pitched voice</strong></li>\n<li>Small genitalia (micropenis)</li>\n<li>Delayed skeletal maturation</li>\n<li>Delayed dentition</li>\n<li>Delayed puberty (sexual infantilism)</li>\n<li>Doll-like facial appearance: small, round facies, frontal prominence, depressed nasal bridge (saddle nose), eyes may bulge, underdeveloped mandible and chin, normal head circumference but craniofacial disproportion due to small facies</li>\n<li>Short neck</li>\n<li><strong>Normal intelligence</strong>.</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2401",
      "difficulty": "medium"
    },
    {
      "text": "You are evaluating children with short stature on whether they are eligible to receive growth hormone therapy as per FDA guidelines. In which of the following children would you prescribe it?",
      "choices": [
        {
          "id": 1,
          "text": "An 8 year old with Laron dwarfism"
        },
        {
          "id": 2,
          "text": "A neonate diagnosed with congenital hypothyroidism"
        },
        {
          "id": 3,
          "text": "A  7 year old with Chronic kidney disease"
        },
        {
          "id": 4,
          "text": "A 6 year old diagnosed with Maternal deprivation dwarfism"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Chronic kidney disease</strong> is an <strong>FDA-approved indication</strong> for growth hormone (GH) therapy.</p>\n<p>Renal failure is a state of <strong>GH resistance</strong>.&nbsp;<strong>Moderate-to-severe growth retardation</strong> in chronic kidney disease is associated with increased morbidity and mortality. GH therapy with recombinant growth hormone&nbsp;has been shown to <strong>improve catch-up growth</strong> and to allow the child to achieve normal <strong>adult height</strong>; the final adult height is still significantly below the genetic target.</p>\n<p><strong>FDA-approved indications</strong>&nbsp;for growth hormone (GH) treatment-</p>\n<ol>\n<li>GH deficiency</li>\n<li>Turner's Syndrome</li>\n<li>Chronic Renal Failure before Transplantation</li>\n<li>Small for Gestational Age / Short Stature</li>\n<li>Idiopathic Short Stature</li>\n<li>Noonan Syndrome</li>\n<li>Prader-Willi Syndrome</li>\n<li>AIDS-related wasting</li>\n<li>Malabsorption associated with the short-bowel syndrome</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2405",
      "difficulty": "hard"
    },
    {
      "text": "Chotu, a 5-year-old boy is on regular outpatient follow-up for growth hormone deficiency diagnosed 2 weeks back. He is planned for recombinant growth hormone therapy. All of the following are possible side effects except-",
      "choices": [
        {
          "id": 1,
          "text": "Type 1 diabetes mellitus"
        },
        {
          "id": 2,
          "text": "Pseudotumor cerebri"
        },
        {
          "id": 3,
          "text": "Slipped capital femoral epiphysis"
        },
        {
          "id": 4,
          "text": "Gynecomastia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The use of recombinant growth hormone is associated with the risk of&nbsp;<strong>type 2 diabetes mellitus</strong>&nbsp;(not type 1 diabetes mellitus).</p>\n<p><strong>Other adverse effects:</strong></p>\n<ul>\n<li>Pseudotumor cerebri</li>\n<li>Slipped capital femoral epiphysis</li>\n<li>Gynecomastia</li>\n<li>Worsening of scoliosis</li>\n</ul>\n<p>Children who have been treated with rhGH have a higher risk of developing <strong>hemorrhagic strokes</strong> in adulthood. <br />Some studies show an <strong>increased risk</strong> of <strong>new</strong><strong>&nbsp;neoplasms</strong> in cancer survivors.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1993",
      "difficulty": "medium"
    },
    {
      "text": "The most common pituitary adenoma diagnosed in childhood is _________.",
      "choices": [
        {
          "id": 1,
          "text": "Prolactinoma"
        },
        {
          "id": 2,
          "text": "Corticotropinoma"
        },
        {
          "id": 3,
          "text": "Somatotropinoma"
        },
        {
          "id": 4,
          "text": "Gonadotropinoma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most commonly diagnosed adenomas during childhood are <strong>prolactinoma &gt; corticotropinoma &gt; somatotropinoma.</strong></p>\n<p>Note:</p>\n<p>Hypothalamic hamartomas that secrete excess gonadotropin-releasing hormone can cause precocious puberty.</p>\n<p><strong>Â </strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2462",
      "difficulty": "medium"
    },
    {
      "text": "Akash is the tallest kid in his 5th-grade class. While at a routine visit for a booster immunization, his pediatrician plots his height on a growth chart and finds him to be above 3-SD for his age. Which of the following can be an endocrine cause for his height?",
      "choices": [
        {
          "id": 1,
          "text": "Sotos syndrome"
        },
        {
          "id": 2,
          "text": "McCune-Albright syndrome"
        },
        {
          "id": 3,
          "text": "Fragile X syndrome"
        },
        {
          "id": 4,
          "text": "Beckwith-Wiedemann syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>McCune&ndash;Albright syndrome</strong> (endocrine dysfunction affecting multiple glands) is an&nbsp;<span data-token-index=\"2\" data-reactroot=\"\"><strong>endocrine </strong>cause of <strong>tall stature</strong> in childhood. </span>The <strong>triad</strong> of&nbsp;McCune&ndash;Albright syndrome is <strong>precocious puberty, polyostotic fibrous dysplasia,</strong>&nbsp;and&nbsp;<strong>cafe au lait macules</strong></p>\n<p><strong>Causes of childhood tall stature:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Non-endocrine causes</strong></td>\n<td><strong>Endocrine causes</strong></td>\n</tr>\n<tr>\n<td>Familial (constitutional) tall stature</td>\n<td>Excess GH secretion(pituitary gigantism)</td>\n</tr>\n<tr>\n<td>Cerebral gigantism (Sotos syndrome)</td>\n<td><strong>McCune&ndash;Albright syndrome</strong></td>\n</tr>\n<tr>\n<td>Marfan syndrome</td>\n<td>Precocious puberty</td>\n</tr>\n<tr>\n<td>Fragile X syndrome</td>\n<td>Hyperthyroidism</td>\n</tr>\n<tr>\n<td>Homocystinuria</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Klinefelter syndrome(XXY)</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>XYY syndrome</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Beckwith&ndash;Wiedemann syndrome</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2485",
      "difficulty": "medium"
    },
    {
      "text": "\"Weak giants\" are produced by _________.",
      "choices": [
        {
          "id": 1,
          "text": "Hypothalamic tumors"
        },
        {
          "id": 2,
          "text": "Craniopharyngiomas"
        },
        {
          "id": 3,
          "text": "Pituitary adenomas"
        },
        {
          "id": 4,
          "text": "Pinealomas"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>\"<strong>Weak giants</strong>\" are due to hyperpituitarism that is most commonly produced by <strong>pituitary adenomas</strong>.</p>\n<p><strong>Hyperpituitarism</strong> causes <strong>growth hormone</strong> (GH)<strong> excess</strong>, leading to <strong>tall stature </strong>(giants) with <strong>weak muscles. </strong>Overproduction of GH results in&nbsp;<strong>gigantism</strong>&nbsp;in children (before fusion of bone growth plate) and&nbsp;<strong>acromegaly&nbsp;</strong>in adults.</p>\n<p>Clinical features include:</p>\n<ul>\n<li aria-level=\"1\">Gigantism,&nbsp;prognathism (protrusion of jaw),&nbsp;hypertrophy of frontal bones</li>\n<li aria-level=\"1\">Proximal myopathy (though there is muscle hypertrophy, it is weakened due to atrophy of type II muscle fibers)</li>\n<li>Acral enlargement in hands and feet (due to thickening of soft tissues)</li>\n<li aria-level=\"1\">Visceromegaly:&nbsp;Enlargement of most organs especially the tongue, thyroid, salivary gland, liver, spleen, kidney, and prostate</li>\n<li>Local effects of the adenoma: Headache, visual field defects, raised ICT</li>\n</ul>\n<p>Note: Although hypothalamic hamartomas can also produce gigantism, the most common cause of gigantism is pituitary adenomas.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2467",
      "difficulty": "medium"
    },
    {
      "text": "A young boy is diagnosed to have central diabetes insipidus. A lesion in which of the following nuclei is likely to cause this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Dorsomedial nuclei"
        },
        {
          "id": 2,
          "text": "Supraoptic and Paraventricular nuclei"
        },
        {
          "id": 3,
          "text": "Median preoptic nuclei"
        },
        {
          "id": 4,
          "text": "Ventromedial nuclei"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Lesions in the <strong>supraoptic</strong> and <strong>paraventricular</strong> nuclei of the <strong>hypothalamus</strong> can cause <strong>central diabetes insipidus</strong>.&nbsp;</p>\n<p>These nuclei synthesize <strong>vasopressin,</strong> a 9-amino-acid peptide with <strong>antidiuretic</strong> and <span data-token-index=\"15\" data-reactroot=\"\"><strong>vascular pressor</strong> activity</span>. It is transported to the posterior pituitary via axonal projections, where it is stored for release into the systemic circulation.</p>\n<p>Diabetes insipidus (DI) is characterized by <strong>pathologic polyuria</strong> and <strong>polydipsia</strong> (<strong>&gt;2 L/m&sup2;/24 hr or 5 mL/kg/hr</strong>).&nbsp;It can result from either:</p>\n<ul>\n<li><strong>Vasopressin deficiency</strong> (decreased anti-diuretic hormone production) causes&nbsp;<strong>central DI</strong>.</li>\n<li><strong>Vasopressin insensitivity</strong> at the level of the kidney causes&nbsp;<strong>nephrogenic DI</strong>.</li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2443",
      "difficulty": "easy"
    },
    {
      "text": "A 4-year-old boy was brought by his mother with new-onset nocturnal bedwetting. She also reported, he has been drinking more water for the last 3-4 months. 24-hour urine volume was 4 liters and the urine osmolality was low. ADH assays recorded a value was 0.7 pg/mL. T1 weighted MRI brain indicated an absence of a pituitary bright spot. What is the treatment of choice for his condition?",
      "choices": [
        {
          "id": 1,
          "text": "Leuprolide"
        },
        {
          "id": 2,
          "text": "Thiazide diuretics"
        },
        {
          "id": 3,
          "text": "Desmopressin"
        },
        {
          "id": 4,
          "text": "Terlipressin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of <strong>central</strong>&nbsp;<strong>diabetes insipidus</strong>. The treatment of choice is&nbsp;<strong>desmopressin</strong>. It is&nbsp;a <strong>vasopressin analog</strong> (V2 receptor agonist). It can be administered intranasally, or subcutaneously.&nbsp;</p>\n<p>Option A: Leuprolide&nbsp;is a&nbsp;<strong>GnRH</strong>&nbsp;(gonadotropin-releasing hormone)&nbsp;<strong>analog</strong>&nbsp;used in the treatment of prostate cancer, breast cancer, and endometriosis.</p>\n<p>Option B: Thiazides&nbsp;paradoxically exert an antidiuretic effect in DI but are not the drug of choice. They are generally used in&nbsp;<strong>nephrogenic DI.</strong></p>\n<p>Option D: Terlipressin&nbsp;is a long-acting analog on vasopressin that acts on V1 receptors of vascular smooth muscle. It is used as a vasopressor in shock and acute variceal bleeding.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2453",
      "difficulty": "easy"
    },
    {
      "text": "A 6-year-old boy diagnosed with Wolfram syndrome is admitted to the pediatric ward of your hospital. Which of the following features would you expect to find in this child?",
      "choices": [
        {
          "id": 1,
          "text": "Diabetes mellitus type 2"
        },
        {
          "id": 2,
          "text": "Syndrome of inappropriate ADH secretion"
        },
        {
          "id": 3,
          "text": "Conductive hearing loss"
        },
        {
          "id": 4,
          "text": "Optic atrophy"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Optic Atrophy</strong> is&nbsp;seen in <strong>Wolfram syndrome.</strong> The components of the syndrome are represented by the acronym&nbsp;<strong>DIDMOAD:</strong></p>\n<ul>\n<li><strong>D</strong>iabetes <strong>I</strong>nsipidus</li>\n<li><strong>D</strong>iabetes <strong>M</strong>ellitus (type 1)</li>\n<li><strong>O</strong>ptic <strong>A</strong>trophy</li>\n<li>Neural <strong>D</strong>eafness</li>\n</ul>\n<p>It is caused by mutations of the&nbsp;<strong><em>WFS1</em>&nbsp;gene</strong>.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2451",
      "difficulty": "hard"
    },
    {
      "text": "While working in a tertiary care center,  a  5-year-old girl presents with polyuria, polydipsia, and nocturnal enuresis for the past 1 year. A water deprivation test is done and shows low urine osmolality on stopping the intake of water. On desmopressin administration, there is a 7% rise in urine osmolality.  The treatment of this condition uses all of the following except?",
      "choices": [
        {
          "id": 1,
          "text": "Thiazide diuretics"
        },
        {
          "id": 2,
          "text": "Increased salt intake"
        },
        {
          "id": 3,
          "text": "Amiloride"
        },
        {
          "id": 4,
          "text": "Indomethacin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of<strong> nephrogenic diabetes insipidus</strong>. The treatment includes pharmacological treatment combined with&nbsp;<strong>salt restriction</strong> and not increased salt intake.</p>\n<p>Treatment of nephrogenic diabetes insipidus:</p>\n<ul>\n<li>Adequate water intake along with a low sodium diet</li>\n<li><strong>Thiazide diuretics</strong>: Acts by&nbsp;\n<ul>\n<li aria-level=\"2\">Volume contraction and increases the responsiveness of other parts of the tubule</li>\n<li aria-level=\"2\">Increase the AQP2 channels independent of vasopressin</li>\n</ul>\n</li>\n<li>Potassium-sparing diuretics (triamterene and amiloride): <strong>Amiloride</strong> is the drug of choice for<strong> lithium-induced DI</strong></li>\n<li>Prostaglandin synthesis inhibitor (<strong>indomethacin</strong>)</li>\n</ul><hr><h3>Related Pearl: Water Deprivation test in Diabetes Insipidus</h3><p><strong>Procedure</strong>: Start the test at 4 am by checking the baseline urine osmolality. Deprive the patient of water till 12 pm (8 hours), and then re-check urine osmolality.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4fbb612d53a844a481418c1744026250x1200x1255.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Urine osmolality&nbsp;before water deprivation</td>\n<td>Urine osmolality after water deprivation</td>\n<td>Urine osmolality after desmopressin administration</td>\n</tr>\n<tr>\n<td>Normal&nbsp;</td>\n<td>Normal&nbsp;</td>\n<td>Increases</td>\n<td>No change</td>\n</tr>\n<tr>\n<td>Central DI</td>\n<td>Low</td>\n<td>No change</td>\n<td>&gt;50% increase from baseline</td>\n</tr>\n<tr>\n<td>Nephrogenic DI</td>\n<td>Low</td>\n<td>No change</td>\n<td>&lt;10% increase from baseline</td>\n</tr>\n<tr>\n<td>Primary polydipsia</td>\n<td>Low</td>\n<td>Increases</td>\n<td>No change</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br />Note: Normal urine osmolality- 500-850 mOsm/L<br /><br /></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2447",
      "difficulty": "medium"
    }
  ]
}